Jane Street’s Accendra Health ACH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q2
Sell
-199,700
Closed -$2.91M 9308
2023
Q1
$2.91M Buy
+199,700
New +$3.58M ﹤0.01% 3197
2022
Q3
Sell
-52,300
Closed -$1.65M 10219
2022
Q2
$1.65M Sell
52,300
-1,400
-3% -$50.7K ﹤0.01% 4529
2022
Q1
$2.36M Sell
53,700
-77,900
-59% -$3.34M ﹤0.01% 4429
2021
Q4
$5.72M Sell
131,600
-8,100
-6% -$318K ﹤0.01% 2649
2021
Q3
$4.37M Buy
139,700
+50,200
+56% +$1.98M ﹤0.01% 2961
2021
Q2
$3.79M Buy
89,500
+71,000
+384% +$2.76M ﹤0.01% 3142
2021
Q1
$695K Buy
+18,500
New +$578K ﹤0.01% 6186
2020
Q4
Sell
-70,000
Closed -$1.76M 7931
2020
Q3
$1.76M Buy
70,000
+44,700
+177% +$652K ﹤0.01% 3245
2020
Q2
$193K Buy
+25,300
New +$185K ﹤0.01% 6397

Other funds holding ACH

Jane Street's ACH Position: Q1 2026 in Review

Jane Street sold out of Accendra Health (ACH) in Q1 2026, closing a stake of 1,070,909 shares — an estimated $2.47M sold.

Jane Street first reported a position in ACH in Q2 2013 and held it in 28 quarters. The position peaked at $6.4M in Q3 2025. 142 funds tracked by Wall St. Rank hold ACH as of Q1 2026.

  • Jane Street reported no remaining Accendra Health position as of Q1 2026 after selling out during the quarter.
  • Jane Street sold 1,070,909 Accendra Health shares in Q1 2026, an estimated $2.47M.
  • Jane Street first reported a position in Accendra Health in Q2 2013 and held it in 28 quarters.
  • Jane Street's Accendra Health position peaked at $6.4M in Q3 2025.
  • 142 funds tracked by Wall St. Rank held Accendra Health as of Q1 2026.

Based on Jane Street's 13F filing for Q1 2026, filed 12 May 2026.